GMO Prime Strategy Co.,Ltd. (TYO:5250)
1,137.00
+19.00 (1.70%)
Jun 5, 2026, 3:04 PM JST
GMO Prime Strategy Balance Sheet
Financials in millions JPY. Fiscal year is December - November.
Millions JPY. Fiscal year is Dec - Nov.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Feb '26 Feb 28, 2026 | Nov '25 Nov 30, 2025 | Nov '24 Nov 30, 2024 | Nov '23 Nov 30, 2023 | Nov '22 Nov 30, 2022 | Nov '21 Nov 30, 2021 |
Cash & Equivalents | 1,233 | 1,284 | 1,399 | 1,326 | 558 | 286 |
Cash & Short-Term Investments | 1,233 | 1,284 | 1,399 | 1,326 | 558 | 286 |
Cash Growth | -7.71% | -8.22% | 5.50% | 137.63% | 95.10% | 57.14% |
Accounts Receivable | 93 | 99 | 82 | 86 | 77 | 51 |
Other Receivables | - | 2 | 3 | - | 1 | - |
Receivables | 93 | 101 | 85 | 86 | 78 | 51 |
Inventory | - | - | 8 | - | - | - |
Prepaid Expenses | 40 | 43 | 33 | 27 | 29 | 21 |
Other Current Assets | 4 | 3 | 4 | 4 | 1 | 4 |
Total Current Assets | 1,370 | 1,431 | 1,529 | 1,443 | 666 | 362 |
Property, Plant & Equipment | 4 | 4 | 5 | 1 | 1 | 2 |
Long-Term Investments | 123 | 127 | 70 | 27 | 21 | 22 |
Other Intangible Assets | 44 | 37 | 27 | 28 | 31 | 29 |
Long-Term Deferred Tax Assets | 4 | 5 | 3 | 1 | 7 | - |
Other Long-Term Assets | 2 | 2 | 3 | 2 | 3 | - |
Total Assets | 1,547 | 1,606 | 1,637 | 1,502 | 729 | 415 |
Accounts Payable | 28 | 31 | 23 | 19 | 21 | 10 |
Accrued Expenses | 41 | 37 | 37 | 27 | 30 | 33 |
Current Portion of Long-Term Debt | 35 | 36 | 41 | 28 | 54 | 43 |
Current Income Taxes Payable | 11 | 9 | 25 | 35 | 79 | 36 |
Other Current Liabilities | 41 | 45 | 35 | 39 | 54 | 30 |
Total Current Liabilities | 156 | 158 | 161 | 148 | 238 | 152 |
Long-Term Debt | 18 | 25 | 62 | 54 | 156 | 132 |
Other Long-Term Liabilities | 1 | 2 | 2 | 2 | 2 | - |
Total Liabilities | 175 | 185 | 225 | 204 | 396 | 284 |
Common Stock | 453 | 453 | 444 | 429 | 40 | 40 |
Additional Paid-In Capital | 413 | 413 | 404 | 389 | - | - |
Retained Earnings | 540 | 589 | 556 | 474 | 288 | 91 |
Treasury Stock | -43 | -43 | - | - | - | - |
Comprehensive Income & Other | 9 | 9 | 8 | 6 | 5 | - |
Shareholders' Equity | 1,372 | 1,421 | 1,412 | 1,298 | 333 | 131 |
Total Liabilities & Equity | 1,547 | 1,606 | 1,637 | 1,502 | 729 | 415 |
Total Debt | 53 | 61 | 103 | 82 | 210 | 175 |
Net Cash (Debt) | 1,180 | 1,223 | 1,296 | 1,244 | 348 | 111 |
Net Cash Growth | -5.22% | -5.63% | 4.18% | 257.47% | 213.51% | - |
Net Cash Per Share | 326.30 | 337.53 | 354.95 | 351.84 | 122.11 | 38.95 |
Filing Date Shares Outstanding | 3.51 | 3.51 | 3.53 | 3.48 | 2.85 | 2.85 |
Total Common Shares Outstanding | 3.51 | 3.51 | 3.53 | 3.46 | 2.85 | 2.85 |
Working Capital | 1,214 | 1,273 | 1,368 | 1,295 | 428 | 210 |
Book Value Per Share | 390.66 | 404.62 | 400.28 | 375.26 | 116.84 | 45.96 |
Tangible Book Value | 1,328 | 1,384 | 1,385 | 1,270 | 302 | 102 |
Tangible Book Value Per Share | 378.14 | 394.08 | 392.62 | 367.16 | 105.96 | 35.79 |